p38 MAP kinase regulates rapid matrix metalloproteinase-9 release from eosinophils

Biochemical and Biophysical Research Communications

Volumn 315, Issue 2, 2004, Pages 463-470

  Wiehler, Shahina ^a   Cuvelier, Susan L ^a   Chakrabarti, Subhadeep ^a   Patel, Kamala D ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Degranulation; fMLP; Granulocytes; Inflammation; MAP kinases; Signal transduction; Tumor necrosis factor

Indexed keywords

FORMYLMETHIONYLLEUCYLPHENYLALANINE; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL SECRETION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME MECHANISM; ENZYME REGULATION; ENZYME RELEASE; EOSINOPHIL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

BACTERIA (MICROORGANISMS);

EID: 0842288994     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.01.078     Document Type: Article

References (31)

1. Shapiro S.D., Senior R.M. Matrix metalloproteinases. Matrix degradation and more. Am. J. Respir. Cell Mol. Biol. 20:1999;1100-1102.
2. Shapiro S.D. Matrix metalloproteinase degradation of extracellular matrix: biological consequences. Curr. Opin. Cell Biol. 10:1998;602-608.
3. Murphy G., Willenbrock F., Crabbe T., O'Shea M., Ward R., Atkinson S., O'Connell J., Docherty A. Regulation of matrix metalloproteinase activity. Ann. N. Y. Acad. Sci. 732:1994;31-41.
4. Mautino G., Capony F., Bousquet J., Vignola A.M. Balance in asthma between matrix metalloproteinases and their inhibitors. J. Allergy Clin. Immunol. 104:1999;530-533.
5. Hoshino M., Nakamura Y., Sim J., Shimojo J., Isogai S. Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation. J. Allergy Clin. Immunol. 102:1998;783-788.
6. Kumagai K., Ohno I., Okada S., Ohkawara Y., Suzuki K., Shinya T., Nagase H., Iwata K., Shirato K. Inhibition of matrix metalloproteinases prevents allergen-induced airway inflammation in a murine model of asthma. J. Immunol. 162:1999;4212-4219.
7. Ohno I., Ohtani H., Nitta Y., Suzuki J., Hoshi H., Honma M., Isoyama S., Tanno Y., Tamura G., Yamauchi K., Nagura H., Shirato K. Eosinophils as a source of matrix metalloproteinase-9 in asthmatic airway inflammation. Am. J. Respir. Cell Mol. Biol. 16:1997;212-219.
8. Opdenakker G., Van den Steen P.E., Dubois B., Nelissen I., Van Coillie E., Masure S., Proost P., Van Damme J. Gelatinase B functions as regulator and effector in leukocyte biology. J. Leukoc. Biol. 69:2001;851-859.
9. Schwingshackl A., Duszyk M., Brown N., Moqbel R. Human eosinophils release matrix metalloproteinase-9 on stimulation with TNF-alpha. J. Allergy Clin. Immunol. 104:1999;983-989.
10. Okada S., Kita H., George T.J., Gleich G.J., Leiferman K.M. Migration of eosinophils through basement membrane components in vitro: role of matrix metalloproteinase-9. Am. J. Respir. Cell Mol. Biol. 17:1997;519-528.
11. Cuvelier S.L., Patel K.D. Shear-dependent eosinophil transmigration on interleukin 4-stimulated endothelial cells: a role for endothelium-associated eotaxin-3. J. Exp. Med. 194:2001;1699-1709.
12. Fujisawa T., Kato Y., Terada A., Iguchi K., Kamiya H. Matrix metalloproteinase-9 in peripheral blood eosinophils. Int. Arch. Allergy Immunol. 120:1999;65-69.
13. Zhu X., Sano H., Kim K.P., Sano A., Boetticher E., Munoz N.M., Cho W., Leff A.R. Role of mitogen-activated protein kinase-mediated cytosolic phospholipase A2 activation in arachidonic acid metabolism in human eosinophils. J. Immunol. 167:2001;461-468.
14. Matsuyama G., Ochiai K., Ishihara C., Kagami M., Tomioka H., Koya N. Heterogeneous expression of tumor necrosis factor-alpha receptors I and II on human peripheral eosinophils. Int. Arch. Allergy Immunol. 117:1998;28-33.
15. Kaufman D.R., Choi Y. Signaling by tumor necrosis factor receptors: pathways, paradigms and targets for therapeutic modulation. Int. Rev. Immunol. 18:1999;405-427.
16. Winston B.W., Riches D.W. Activation of p42mapk/erk2 following engagement of tumor necrosis factor receptor CD120a (p55) in mouse macrophages. J. Immunol. 155:1995;1525-1533.
17. Winston B.W., Chan E.D., Johnson G.L., Riches D.W. Activation of p38mapk, MKK3, and MKK4 by TNF-alpha in mouse bone marrow-derived macrophages. J. Immunol. 159:1997;4491-4497.
18. Wong C.K., Zhang J.P., Ip W.K., Lam C.W. Activation of p38 mitogen-activated protein kinase and nuclear factor-kappaB in tumour necrosis factor-induced eotaxin release of human eosinophils. Clin. Exp. Immunol. 128:2002;483-489.
19. Sullivan S.K., McGrath D.A., Liao F., Boehme S.A., Farber J.M., Bacon K.B. MIP-3alpha induces human eosinophil migration and activation of the mitogen-activated protein kinases (p42/p44 MAPK). J. Leukoc. Biol. 66:1999;674-682.
20. Bracke M., Coffer P.J., Lammers J.W., Koenderman L. Analysis of signal transduction pathways regulating cytokine-mediated Fc receptor activation on human eosinophils. J. Immunol. 161:1998;6768-6774.
21. Boehme S.A., Sullivan S.K., Crowe P.D., Santos M., Conlon P.J., Sriramarao P., Bacon K.B. Activation of mitogen-activated protein kinase regulates eotaxin-induced eosinophil migration. J. Immunol. 163:1999;1611-1618.
22. Kankaanranta H., De Souza P.M., Barnes P.J., Salmon M., Giembycz M.A., Lindsay M.A. SB 203580, an inhibitor of p38 mitogen-activated protein kinase, enhances constitutive apoptosis of cytokine-deprived human eosinophils. J. Pharmacol. Exp. Ther. 290:1999;621-628.
23. Schonbeck U., Mach F., Libby P. Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing. J. Immunol. 161:1998;3340-3346.
24. Van den Steen P.E., Proost P., Wuyts A., Van Damme J., Opdenakker G. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. Blood. 96:2000;2673-2681.
25. Mautino G., Oliver N., Chanez P., Bousquet J., Capony F. Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics. Am. J. Respir. Cell Mol. Biol. 17:1997;583-591.
26. Zhu X., Jacobs B., Boetticher E., Myou S., Meliton A., Sano H., Lambertino A.T., Munoz N.M., Leff A.R. IL-5-induced integrin adhesion of human eosinophils caused by ERK1/2-mediated activation of cPLA2. J. Leukoc. Biol. 72:2002;1046-1053.
27. Adachi T., Choudhury B.K., Stafford S., Sur S., Alam R. The differential role of extracellular signal-regulated kinases and p38 mitogen-activated protein kinase in eosinophil functions. J. Immunol. 165:2000;2198-2204.
28. Kampen G.T., Stafford S., Adachi T., Jinquan T., Quan S., Grant J.A., Skov P.S., Poulsen L.K., Alam R. Eotaxin induces degranulation and chemotaxis of eosinophils through the activation of ERK2 and p38 mitogen-activated protein kinases. Blood. 95:2000;1911-1917.
29. Takafuji S., Ishida A., Miyakuni Y., Nakagawa T. Matrix metalloproteinase-9 release from human leukocytes. J. Invest. Allergol. Clin. Immunol. 13:2003;50-55.
30. Hoshino M., Takahashi M., Takai Y., Sim J. Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma. J. Allergy Clin. Immunol. 104:1999;356-363.
31. Vignola A.M., Riccobono L., Mirabella A., Profita M., Chanez P., Bellia V., Mautino G., D'Accardi P., Bousquet J., Bonsignore G. Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. Am. J. Respir. Crit. Care Med. 158:1998;1945-1950.